 | • レポートコード：QYR9ST04749 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がん支持療法薬の世界市場について調査・分析し、がん支持療法薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（G-CSF（顆粒球コロニー刺激因子）、ESA（赤血球生成刺激剤）、制吐薬、ビスホスホネート、オピオイド、NSAID）、用途別（化学療法療法、放射線療法）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがん支持療法薬市場動向 ・主要企業別マーケットシェア ・がん支持療法薬の種類別市場規模2014-2019 （G-CSF（顆粒球コロニー刺激因子）、ESA（赤血球生成刺激剤）、制吐薬、ビスホスホネート、オピオイド、NSAID） ・がん支持療法薬の用途別市場規模2014-2019 （化学療法療法、放射線療法） ・がん支持療法薬の北米市場：主要企業・種類別/用途別市場規模 ・がん支持療法薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がん支持療法薬の中国市場：主要企業・種類別/用途別市場規模 ・がん支持療法薬の日本国内市場：主要企業・種類別/用途別市場規模 ・がん支持療法薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・がん支持療法薬のインド市場：主要企業・種類別/用途別市場規模 ・がん支持療法薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Amgen、Johnson & Johnson、Merck、Roche、Helsinn Healthcare、Heron Pharma、Tesaro） ・がん支持療法薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy.Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailored treatments are anticipated to drive the growth.
In 2018, the global Cancer Supportive Care Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cancer Supportive Care Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Supportive Care Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Amgen
Johnson & Johnson
Merck
Roche
Helsinn Healthcare
Heron Pharma
Tesaro
…
Market segment by Type, the product can be split into
G-CSFs (Granulocyte-colony Stimulating Factors)
ESAs (Erythropoiesis Stimulating Agents)
Anti-emetics
Bisphosphonates
Opioids
NSAIDs
Market segment by Application, split into
Chemotherapy Therapy
Radiation Therapy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Supportive Care Drugs status, future forecast, growth opportunity, key market and key players.
To present the Cancer Supportive Care Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Supportive Care Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Supportive Care Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 G-CSFs (Granulocyte-colony Stimulating Factors)
1.4.3 ESAs (Erythropoiesis Stimulating Agents)
1.4.4 Anti-emetics
1.4.5 Bisphosphonates
1.4.6 Opioids
1.4.7 NSAIDs
1.5 Market by Application
1.5.1 Global Cancer Supportive Care Drugs Market Share by Application (2019-2025)
1.5.2 Chemotherapy Therapy
1.5.3 Radiation Therapy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Supportive Care Drugs Market Size
2.2 Cancer Supportive Care Drugs Growth Trends by Regions
2.2.1 Cancer Supportive Care Drugs Market Size by Regions (2019-2025)
2.2.2 Cancer Supportive Care Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Cancer Supportive Care Drugs Market Size by by Players
3.1.1 Global Cancer Supportive Care Drugs Revenue by by Players (2014-2019)
3.1.2 Global Cancer Supportive Care Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Cancer Supportive Care Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Supportive Care Drugs Key Players Head office and Area Served
3.3 Key Players Cancer Supportive Care Drugs Product/Solution/Service
3.4 Date of Enter into Cancer Supportive Care Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Supportive Care Drugs Market Size by Type (2014-2019)
4.2 Global Cancer Supportive Care Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Cancer Supportive Care Drugs Market Size (2014-2019)
5.2 Cancer Supportive Care Drugs Key Players in North America
5.3 North America Cancer Supportive Care Drugs Market Size by Type
5.4 North America Cancer Supportive Care Drugs Market Size by Application
6 Europe
6.1 Europe Cancer Supportive Care Drugs Market Size (2014-2019)
6.2 Cancer Supportive Care Drugs Key Players in Europe
6.3 Europe Cancer Supportive Care Drugs Market Size by Type
6.4 Europe Cancer Supportive Care Drugs Market Size by Application
7 China
7.1 China Cancer Supportive Care Drugs Market Size (2014-2019)
7.2 Cancer Supportive Care Drugs Key Players in China
7.3 China Cancer Supportive Care Drugs Market Size by Type
7.4 China Cancer Supportive Care Drugs Market Size by Application
8 Japan
8.1 Japan Cancer Supportive Care Drugs Market Size (2014-2019)
8.2 Cancer Supportive Care Drugs Key Players in Japan
8.3 Japan Cancer Supportive Care Drugs Market Size by Type
8.4 Japan Cancer Supportive Care Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Supportive Care Drugs Market Size (2014-2019)
9.2 Cancer Supportive Care Drugs Key Players in Southeast Asia
9.3 Southeast Asia Cancer Supportive Care Drugs Market Size by Type
9.4 Southeast Asia Cancer Supportive Care Drugs Market Size by Application
10 India
10.1 India Cancer Supportive Care Drugs Market Size (2014-2019)
10.2 Cancer Supportive Care Drugs Key Players in India
10.3 India Cancer Supportive Care Drugs Market Size by Type
10.4 India Cancer Supportive Care Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Supportive Care Drugs Market Size (2014-2019)
11.2 Cancer Supportive Care Drugs Key Players in Central & South America
11.3 Central & South America Cancer Supportive Care Drugs Market Size by Type
11.4 Central & South America Cancer Supportive Care Drugs Market Size by Application
12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Supportive Care Drugs Introduction
12.1.4 Amgen Revenue in Cancer Supportive Care Drugs Business (2014-2019))
12.1.5 Amgen Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Supportive Care Drugs Introduction
12.2.4 Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Supportive Care Drugs Introduction
12.3.4 Merck Revenue in Cancer Supportive Care Drugs Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Supportive Care Drugs Introduction
12.4.4 Roche Revenue in Cancer Supportive Care Drugs Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Helsinn Healthcare
12.5.1 Helsinn Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Supportive Care Drugs Introduction
12.5.4 Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2014-2019)
12.5.5 Helsinn Healthcare Recent Development
12.6 Heron Pharma
12.6.1 Heron Pharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Supportive Care Drugs Introduction
12.6.4 Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2014-2019)
12.6.5 Heron Pharma Recent Development
12.7 Tesaro
12.7.1 Tesaro Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Supportive Care Drugs Introduction
12.7.4 Tesaro Revenue in Cancer Supportive Care Drugs Business (2014-2019)
12.7.5 Tesaro Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cancer Supportive Care Drugs Key Market Segments
Table Key Players Cancer Supportive Care Drugs Covered
Table Global Cancer Supportive Care Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer G-CSFs (Granulocyte-colony Stimulating Factors) Figures
Table Key Players of G-CSFs (Granulocyte-colony Stimulating Factors)
Figuer ESAs (Erythropoiesis Stimulating Agents) Figures
Table Key Players of ESAs (Erythropoiesis Stimulating Agents)
Figuer Anti-emetics Figures
Table Key Players of Anti-emetics
Figuer Bisphosphonates Figures
Table Key Players of Bisphosphonates
Figuer Opioids Figures
Table Key Players of Opioids
Figuer NSAIDs Figures
Table Key Players of NSAIDs
Table Global Cancer Supportive Care Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Cancer Supportive Care Drugs Market Share by Application in 2018 & 2025
Figure Chemotherapy Therapy Case Studies
Figure Radiation Therapy Case Studies
Figure Cancer Supportive Care Drugs Report Years Considered
Figure Global Cancer Supportive Care Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Supportive Care Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Cancer Supportive Care Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Cancer Supportive Care Drugs Market Share by Regions 2014-2019
Figure Global Cancer Supportive Care Drugs Market Share by Regions 2014-2019
Figure Global Cancer Supportive Care Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Cancer Supportive Care Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Cancer Supportive Care Drugs Market Share by by Players (2014-2019)
Figure Global Cancer Supportive Care Drugs Market Share by by Players in 2018
Table Global Cancer Supportive Care Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Supportive Care Drugs Product/Solution/Service
Table Date of Enter into Cancer Supportive Care Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Supportive Care Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Supportive Care Drugs Market Size Share by Type (2014-2019)
Figure Global Cancer Supportive Care Drugs Market Size Market Share by Type (2014-2019)
Table Global Cancer Supportive Care Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Supportive Care Drugs Market Size Share by Application (2014-2019)
Figure Global Cancer Supportive Care Drugs Market Size Market Share by Application (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Market Share by Application in 2018
Figure North America Cancer Supportive Care Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Cancer Supportive Care Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Cancer Supportive Care Drugs Market Share (2018-2019)
Table North America Cancer Supportive Care Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Cancer Supportive Care Drugs Market Share by Type 2014-2019
Table North America Cancer Supportive Care Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Cancer Supportive Care Drugs Market Share by Application 2014-2019
Figure Europe Cancer Supportive Care Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Supportive Care Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Supportive Care Drugs Market Share (2018-2019)
Table Europe Cancer Supportive Care Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Cancer Supportive Care Drugs Market Share by Type 2014-2019
Table Europe Cancer Supportive Care Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Cancer Supportive Care Drugs Market Share by Application 2014-2019
Figure China Cancer Supportive Care Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Supportive Care Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Supportive Care Drugs Market Share (2018-2019)
Table China Cancer Supportive Care Drugs Market Size by Type 2014-2019 (Million US$)
Table China Cancer Supportive Care Drugs Market Share by Type 2014-2019
Table China Cancer Supportive Care Drugs Market Size by Application 2014-2019 (Million US$)
Table China Cancer Supportive Care Drugs Market Share by Application 2014-2019
Figure Japan Cancer Supportive Care Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Supportive Care Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Supportive Care Drugs Market Share (2018-2019)
Table Japan Cancer Supportive Care Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Cancer Supportive Care Drugs Market Share by Type 2014-2019
Table Japan Cancer Supportive Care Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Cancer Supportive Care Drugs Market Share by Application 2014-2019
Figure Southeast Asia Cancer Supportive Care Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Supportive Care Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Supportive Care Drugs Market Share (2018-2019)
Table Southeast Asia Cancer Supportive Care Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Cancer Supportive Care Drugs Market Share by Type 2014-2019
Table Southeast Asia Cancer Supportive Care Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Cancer Supportive Care Drugs Market Share by Application 2014-2019
Figure India Cancer Supportive Care Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Supportive Care Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Supportive Care Drugs Market Share (2018-2019)
Table India Cancer Supportive Care Drugs Market Size by Type 2014-2019 (Million US$)
Table India Cancer Supportive Care Drugs Market Share by Type 2014-2019
Table India Cancer Supportive Care Drugs Market Size by Application 2014-2019 (Million US$)
Table India Cancer Supportive Care Drugs Market Share by Application 2014-2019
Figure Central & South America Cancer Supportive Care Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Supportive Care Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Supportive Care Drugs Market Share (2018-2019)
Table Central & South America Cancer Supportive Care Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Cancer Supportive Care Drugs Market Share by Type 2014-2019
Table Central & South America Cancer Supportive Care Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Cancer Supportive Care Drugs Market Share by Application 2014-2019
Table Amgen Company Details
Table Amgen Revenue in Cancer Supportive Care Drugs Business 2014-2019 (Million US$)
Figure Amgen Revenue Growth Rate in Cancer Supportive Care Drugs Business (2014-2019)
Table Amgen Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Cancer Supportive Care Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Cancer Supportive Care Drugs Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Cancer Supportive Care Drugs Business (2014-2019)
Table Merck Recent Development
Table Roche Company Details
Table Roche Revenue in Cancer Supportive Care Drugs Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Cancer Supportive Care Drugs Business (2014-2019)
Table Roche Recent Development
Table Helsinn Healthcare Company Details
Table Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business 2014-2019 (Million US$)
Figure Helsinn Healthcare Revenue Growth Rate in Cancer Supportive Care Drugs Business (2014-2019)
Table Helsinn Healthcare Recent Development
Table Heron Pharma Company Details
Table Heron Pharma Revenue in Cancer Supportive Care Drugs Business 2014-2019 (Million US$)
Figure Heron Pharma Revenue Growth Rate in Cancer Supportive Care Drugs Business (2014-2019)
Table Heron Pharma Recent Development
Table Tesaro Company Details
Table Tesaro Revenue in Cancer Supportive Care Drugs Business 2014-2019 (Million US$)
Figure Tesaro Revenue Growth Rate in Cancer Supportive Care Drugs Business (2014-2019)
Table Tesaro Recent Development
Table Global Cancer Supportive Care Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Supportive Care Drugs Market Size Share by Regions (2019-2025)
Figure Global Cancer Supportive Care Drugs Market Size Share by Regions in 2025
Figure North America Cancer Supportive Care Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Supportive Care Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Supportive Care Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Supportive Care Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Supportive Care Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Supportive Care Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Supportive Care Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Supportive Care Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Supportive Care Drugs Market Size by Product (2019-2025)
Figure Global Cancer Supportive Care Drugs Market Size by Product in 2025
Table Global Cancer Supportive Care Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Supportive Care Drugs Market Size by Application (2019-2025)
Figure Global Cancer Supportive Care Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
がん支持療法の世界市場：インサイト・予測 The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.With growing prevalence of cancer,…- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …